Navigation Links
Data Published in the Journal of the American Society of Nephrology Shows Daily Home Hemodialysis Patients with the NxStage System One Have Significantly Lower Risk of Mortality and Improved 3-Year Survival Versus Patients on Conventional Hemodialys
Date:2/23/2012

emographic characteristics, disease severity measures, transplant waiting list and other severity of disease covariates that could impact mortality. The study demonstrated that in the intention-to-treat analysis:

  • the all-cause mortality hazard ratio was 0.87 (p=0.01) in as-treated patient analyses when compared with patients receiving conventional thrice-weekly in-center dialysis,
  • the cause-specific mortality hazard ratios were 0.92 (p=0.34) for cardiovascular disease; 1.13 (p=0.41) for infection; 0.63 (p=0.03) for cachexia/dialysis withdrawal; 1.06 (p=0.69) for other specified cause; and 0.59 (p<0.01) for unknown cause. For this study, hazard ratios of <1 indicate reduced risk of death, whereas ratios of >1 indicate a greater risk.  Mortality results in the study are associated with a reduced risk of death from cachexia/dialysis withdrawal and unknown causes.

"This study is the largest and most comprehensively matched to date looking at survival in the daily home hemodialysis population, and the positive results are encouraging," said Dr. Allan Collins, MD, FACP, professor of medicine, University of Minnesota, and director, Chronic Disease Research Group. "These results add to the recently published body of large, well conducted studies pointing to significant potential benefits of home and more frequent hemodialysis therapies. Going forward, we must consider the possibility that conventional thrice-weekly treatment may be inadequate for addressing the critical problems of persistent fluid overload, hypertension, and left ventricular hypertrophy, as well as the resultant complications including patient mortality."

"This study uses the best statistical methods available and clearly demonstrates that more frequent home hemodialysis with the NxStage System One can significantly lower mortality and improve survival for thousands of dialysis patients," said Jeffrey H. Burbank, Chief
'/>"/>

SOURCE NxStage Medical, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Positive Kuvan(TM) Pivotal Phase 3 Trial Results Published in The Lancet
2. Adlyfe Study on the Detection of Misfolded Proteins Published in the Journal Transfusion
3. Nebivolol Lowers Blood Pressure in Mild-to-Moderate Hypertensive Patients as Demonstrated in a Study Published in the Journal of Clinical Hypertension
4. Results from Study Evaluating PROCRIT(R) in Intensive Care Unit Patients Published in New England Journal of Medicine
5. Newly Published Phase II Study Shows the Investigational Drug Vandetanib Prolongs Progression-Free Survival in Patients with Advanced Non-Small Cell Lung Cancer (NSCLC)
6. Study Published in Endocrinology Reports Potential of Modigene Technology to Extend Duration of Protein Drugs
7. New Data Published in Neurology Show Once-Daily Lamictal XR Significantly Reduced Partial Seizures in Patients with Epilepsy
8. Studies Showing Significant Survival Improvement with Taxotere(R)-based Regimens in the Induction Treatment of Patients with Locally Advanced Head and Neck Cancer are Published in the Same Issue of the New England Journal of Medicine
9. Nebivolol Lowers Blood Pressure in African Americans With Stage I-II Hypertension as Demonstrated in a Study Published in the Journal of Clinical Hypertension
10. UPDATE: Nebivolol Lowers Blood Pressure in African Americans With Stage I-II Hypertension as Demonstrated in a Study Published in the Journal of Clinical Hypertension
11. Tumor Eradication Article Published by Cancer Research
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/3/2015)... SEATTLE , June 3, 2015 ... acquire Northeast Pharmaceuticals, Inc., bringing together two pharmacy organizations ... with mental illness. Both companies have strong reputations for ... their customers. Genoa ... the behavioral health community and those affiliated with managing ...
(Date:6/3/2015)... , June 3, 2015 Creekridge Capital, ... of its sales channels by adding two new sales ... as a Regional Sales Manager and Stefanie Stark ... Mr. Puma comes to Creekridge with over 20 ... his role at Creekridge, Mr. Puma will be responsible ...
(Date:6/3/2015)...  Halozyme Therapeutics, Inc. (NASDAQ: HALO ) ... with AbbVie (NYSE: ABBV ) to develop and ... ENHANZE ™ platform. Under ... an initial $23 million payment, followed by milestone ... up to nine collaboration targets. These payments are ...
Breaking Medicine Technology:Genoa, a QoL Healthcare Company Acquires Northeast Pharmaceuticals, Inc. 2Creekridge Capital Strengthens Sales Team 2Halozyme Enters Into Global Collaboration and Licensing Agreement With AbbVie 2Halozyme Enters Into Global Collaboration and Licensing Agreement With AbbVie 3
... 3, 2011 Reportlinker.com announces that a new market ... Probiotics and Prebiotics in Clinical Nutrition ... Introduction Overall sales of clinical nutrition ... US and EU as well as rising incidence of ...
... May 3, 2011 Researchers from the University of ... American Roentgen Ray Society 2011 Annual Meeting ... and reduce radiation exposure for breast cancer patients.   ... systems that can show the location as well as ...
Cached Medicine Technology:Reportlinker Adds Probiotics and Prebiotics in Clinical Nutrition 2Reportlinker Adds Probiotics and Prebiotics in Clinical Nutrition 3Reportlinker Adds Probiotics and Prebiotics in Clinical Nutrition 4Study Shows Same Day PET-Guided Biopsy May Expedite Pre-Operative Work-up For Breast Cancer Patients and Reduce Radiation Exposure 2
(Date:6/3/2015)... Pittsburgh, Pa (PRWEB) June 03, 2015 EMBARGOED ... , Lower Birth Weight Associated with Proximity of Mother’s Home ... women living close to a high density of natural gas ... babies with lower birth weights than women living farther from ... School of Public Health analysis of southwestern Pennsylvania birth ...
(Date:6/3/2015)... 03, 2015 Johnson & Johnson and ... million to resolve a Risperdal lawsuit ( http://www.risperdallawsuit2014.com/ ) ... company allegedly used to market the antipsychotic drug. ... that the Arkansas Attorney General moved to dismiss the ... The Risperdal settlement amounts to just a fraction of ...
(Date:6/3/2015)... Follow us on LinkedIn – ... treatment on account of their better mode of action ... rheumatoid arthritis. The industry is expected to witness a ... drugs to biopharmaceuticals over the coming years. The high ... therapies, and recombinant proteins has attracted industry players to ...
(Date:6/3/2015)... June 03, 2015 Dr. Steven Reisman, a ... Diagnostic Center ( http://www.newyorkcardiac.com ) located in NYC, announced today ... to his practice. In most cases, depending on the level ... day they call, they will be seen by a cardiologist ... as a cardiologist is to ensure that people who have ...
(Date:6/3/2015)... (PRWEB) June 03, 2015 VeoMed ... to expand online and mobile access to premier ... and Maintenance of Certification (MOC) activities. ... VeoMed’s innovative courses to Decker’s extensive lists of ... in purchasing access to VeoMed’s premier online and ...
Breaking Medicine News(10 mins):Health News:Fracking Proximity Associated with Lower Birth Weight 2Health News:Fracking Proximity Associated with Lower Birth Weight 3Health News:Fracking Proximity Associated with Lower Birth Weight 4Health News:Risperdal Lawsuit News: Johnson & Johnson, Janssen Settle Arkansas Marketing Case for $7.8 Million 2Health News:Risperdal Lawsuit News: Johnson & Johnson, Janssen Settle Arkansas Marketing Case for $7.8 Million 3Health News:Risperdal Lawsuit News: Johnson & Johnson, Janssen Settle Arkansas Marketing Case for $7.8 Million 4Health News:Superior Efficacy of Biopharmaceuticals Against Chronic Diseases Drives the Global Biopharmaceuticals Market, According to a New Report by Global Industry Analysts, Inc. 2Health News:Superior Efficacy of Biopharmaceuticals Against Chronic Diseases Drives the Global Biopharmaceuticals Market, According to a New Report by Global Industry Analysts, Inc. 3Health News:Superior Efficacy of Biopharmaceuticals Against Chronic Diseases Drives the Global Biopharmaceuticals Market, According to a New Report by Global Industry Analysts, Inc. 4Health News:NYC Cardiologist, Dr. Steven Reisman, Announces Same Day and Evening Appointments 2Health News:VeoMed and Decker Intellectual Properties, the Owner of Scientific American Medicine, Announce a Partnership to Expand Access to Premier Online CME Courses 2
... be especially diligent about having routine screening colonoscopies, results ... at Buffalo indicate. , Their findings show that persons ... polyps, known as adenomas, and advanced adenomas than men ... were presented Oct. 19 at a 10:30 a.m. session ...
... Dogs may not only be man,s best friend, they ... children with special needs. According to a new Universit de ... anxiety and enhance the socialization skills of children with Autism ... Psychoneuroendocrinology may be a relatively simple solution to help ...
... is not a foreign sight. But what about a turtle or ... fact, according to Gordon Burghardt, a psychology professor at the University ... monkeys -- need a little play time. "I studied ... never saw anything that I thought was play. Then I had ...
... SEATTLE, Wash.October 18, 2010Researchers at the Allen Institute for ... different activity patterns in the brain in individuals with ... individual differences in the effectiveness and side-effect profiles of ... The study is available in this week,s online early ...
... Oct. 19 (HealthDay News) -- People with depression and ... undergoing surgery, a new study suggests. U.S. researchers ... care units between Oct. 1, 2003 and Sept. 30, ... existing psychiatric condition, including 5,500 (15.5 percent) with depression, ...
... , MONDAY, Oct. 18 (HealthDay News) -- Invasive dental procedures ... heart attack and stroke, researchers say. But the increase ... "I don,t want to downplay this entirely, because we ... just after dental work was done among patients undergoing invasive ...
Cached Medicine News:Health News:Prostate cancer patients are at increased risk of precancerous colon polyps 2Health News:Children's best friend 2Health News:UT professor defines play, discovers even turtles need recess 2Health News:Gene activity in the brain depends on genetic background 2Health News:Depression, Anxiety May Raise Surgery Risks 2Health News:Invasive Dentistry May Raise Short-Term Heart, Stroke Risk 2Health News:Invasive Dentistry May Raise Short-Term Heart, Stroke Risk 3
... on-the-spot reference guide for ... On the wards, in ... or at the bedside, ... access to reliable, clinically ...
This easy-to-navigate reference provides clear, current, clinically proven recommendations for diagnosis and treatment of neurologic disorders....
... enable all those involved with healthcare decisions ... very latest evidence in their field of ... each year as the volume of evidence ... delivering the best single source available for ...
Treatment Strategies in Cardiovascular Medicine...
Medicine Products: